Connection

MARTIN ANDREANSKY to Male

This is a "connection" page, showing publications MARTIN ANDREANSKY has written about Male.
Connection Strength

0.064
  1. Intra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory Thrombocytopenia in Children With Gastrointestinal Graft-Versus-Host Disease. Pediatr Blood Cancer. 2015 Dec; 62(12):2226-8.
    View in: PubMed
    Score: 0.021
  2. Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child. Pediatr Pulmonol. 2010 Apr; 45(4):411.
    View in: PubMed
    Score: 0.015
  3. Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients. Biol Blood Marrow Transplant. 2019 03; 25(3):556-561.
    View in: PubMed
    Score: 0.007
  4. Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial. Biol Blood Marrow Transplant. 2018 06; 24(6):1216-1222.
    View in: PubMed
    Score: 0.006
  5. A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24; 128(21):2561-2567.
    View in: PubMed
    Score: 0.006
  6. Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. Am J Hematol. 2015 Dec; 90(12):1093-8.
    View in: PubMed
    Score: 0.005
  7. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia. 2004 Mar; 18(3):499-504.
    View in: PubMed
    Score: 0.002
  8. Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. Br J Haematol. 2003 Oct; 123(2):243-52.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.